Latest results presented at the Hematologic Neoplasia & Immunologic Therapies Seminar

Dr. Filip Garbicz recently presented his research at the Hematologic Neoplasia & Immunologic Therapies Seminar. His talk, titled "Modeling of MYD88 L265P Mutation and Chromosome 6q Deletion in Murine B Cells: Toward a Mouse Model of Waldenström's Macroglobulinemia," focused on developing a genetically engineered murine model to better understand the aberrations associated with Waldenström's Macroglobulinemia.